Dr. Jörg Schreiber
Chairman
Dr. Jörg Schreiber has over 20 years experience in the diagnostic industry, whilst working with a global leader in the sector. Jörg joined Boehringer Mannheim in 1986, which became Roche Diagnostics. During his time at Roche, he held key senior roles including Vice President for R&D and Special Projects in the US. Dr. Schreiber holds a Ph.D. in physics from Giessen University, Germany, and also holds several board positions in professional, civic and art organizations, where he works in an interdisciplinary context.
Dr. Anna Kluczewska
President and CEO
Dr. Kluczewska is a highly qualified clinician with former global product management experience at Baxter Healthcare's BioSurgery Division. Anna oversaw product management in over 50 countries. Start up company experience includes general and operations management, intellectual property development, capital raising and investor relations, and continuing executive management of seed project through to cash-flow-positive publicly listed company. Dr. Kluczewska is also a Member of the Advisory Board to the Chemistry Centre of Western Australia.
Prof. Leigh Canham
Director and Chief Scientific Officer
Professor Leigh Canham has spent the past twenty years conducting research on differing aspects of silicon technology. He has made two seminal discoveries at the former UK Government Defense Evaluation and Research Agency (DERA - now QinetiQ); that nanostructured silicon can emit light efficiently (1990); and that silicon can be rendered biodegradable (1995). Professor Canham is the world's foremost authority on porous silicon.
